Management of Young Breast Cancer Patients With de Novo Genetic Mutations

A 24-year-old woman presents to her primary care provider with a mass in her left breast. Examination confirms a 2.2-cm mass in the upper outer quadrant, with a single mobile axillary node that is firm to palpation.

Breast Cancer

Tumor Genome Profiling Not Ready for Routine Clinical Use

Leah Lawrence

News | March 05, 2015 | Cancer and Genetics, Breast Cancer, Breast Cancer Targets, MBCC 2015

By Leah Lawrence

The use of tumor genome profiling to identify actionable or targetable mutations in women with breast cancer is not ready for routine use in clinical practice.

Protecting Ovary Function During Breast Cancer Chemotherapy

Anna Azvolinsky, PhD

News | March 04, 2015 | Breast Cancer, Breast Health, Pregnancy and Birth

By Anna Azvolinsky, PhD

The risk of early, sudden-onset menopause in women treated for early-stage breast cancer can be reduced with goserelin, a gonadotropin-releasing hormone agonist.

MR Spectroscopy Shows Early Warning Signs for Women with BRCA

Diagnostic Imaging Staff

News | March 04, 2015 | Breast Imaging, Breast Cancer, MRI

By Diagnostic Imaging Staff

Localized correlated spectroscopy may show signs of biochemical abnormalities, possibly signaling breast cancer among women with BRCA gene.

First-Line Option Clear in Sequencing of HER2-Positive Breast Cancer Treatments

Leah Lawrence

News | March 04, 2015 | MBCC 2015, Breast Cancer, Breast Cancer Targets, HER2-Positive Breast Cancer

By Leah Lawrence

As more treatment options become available for metastatic HER2-positive breast cancer, some questions regarding the optimal sequencing of therapies remain.

Breast Cancer Not Overdiagnosed by Mammography

News | March 03, 2015 | MBCC 2015, Breast Cancer

By Leah Lawrence

The idea that breast cancer is overdiagnosed is being perpetuated in an effort to reduce access to breast cancer screening, according to a presentation at MBCC.